How to Take the Wegovy Pill Each Morning

Take the Wegovy pill on an empty stomach each morning with up to 4 ounces of water, and wait at least 30 minutes before eating, drinking or other tablets (Wegovy label, 2.1). The shot has no such rules. The pill steps up every 30 days: 1.5 mg, 4 mg, 9 mg, then 25 mg from day 91 (label, 2.3).

Key facts

• The FDA approved Wegovy tablets on December 22, 2025, for weight reduction and, in adults with heart disease, to lower the risk of heart attack and stroke (FDA approval letter).
• Only about 1 to 2% of the semaglutide in a tablet reaches the blood, and the level peaks about 1 hour after it (Wegovy label, section 12.3).
• A missed tablet is skipped, unlike a late weekly shot with its own missed-dose window, and two tablets are never taken on one day (Wegovy label, sections 2.1 and 2.4).
• With type 2 diabetes, the tablets were not studied for weight loss and blood levels can run lower than on the shot (Wegovy label, section 8.6).

How to take the Wegovy pill

The label gives these instructions for each tablet (Wegovy label, section 2.1):

1. Take it in the morning, on an empty stomach.
2. Swallow it with water only, up to 4 ounces. No coffee, tea, juice or other drinks.
3. Swallow it whole. Do not split, crush, chew or dissolve it.
4. Wait at least 30 minutes before eating, drinking anything else or taking other oral medicines.
5. Take no more than one tablet a day.

For example, a tablet at 7:00 with up to 4 oz of water means breakfast, coffee and any other tablets from 7:30. Noting the time of the tablet and of your first food or drink shows whether the wait is slipping.

Why the water and the 30 minutes matter

Semaglutide from a tablet is absorbed mainly in the stomach, helped by an absorption enhancer called SNAC, and only about 1 to 2% of each dose reaches the blood (Wegovy label, section 12.3). The water limit and the wait both come from the label’s absorption studies.

More semaglutide was absorbed with 50 mL of water than with 240 mL, about one full 8-ounce glass, and 120 mL did no worse than 50 mL (Wegovy label, section 12.3). Absorption also rose as the fast after the dose lengthened from 15 minutes to 30, 60 and 120 (Wegovy label, section 12.3).

Other morning medicines

Levothyroxine for thyroid conditions also needs an empty stomach; the Synthroid label asks for it 30 to 60 minutes before breakfast (Synthroid label, section 2.1). Neither label says which of the two to take first.

In a study with the semaglutide tablet, levothyroxine exposure rose by 33%, and the Wegovy label advises closer monitoring of oral medicines that need it (Wegovy label, section 7.2). Ask your prescriber or pharmacist how to order the two tablets, and whether your thyroid levels should be checked after you start. Ask too about any other morning tablet that needs close monitoring.

Wegovy pill dosing schedule

Each step lasts 30 days, so the 25 mg maintenance dose starts on day 91 at the earliest (Wegovy label, section 2.3).

If a step brings side effects you cannot manage, the label allows the next increase to be delayed. If 25 mg is not tolerated, it suggests switching to the Wegovy injection at 1.7 mg a week (Wegovy label, section 2.3). The shot climbs in 4-week steps instead and reaches 2.4 mg in week 17, on a separate Wegovy ladder (Wegovy label, section 2.2).

Wegovy pill vs injection

Pill and shot both deliver semaglutide, with these differences in the Wegovy label and each form’s main trial (Wegovy label; STEP 1, Wilding et al., NEJM 2021; OASIS 4, Wharton et al., NEJM 2025).

The weight results come from separate trials. In people with overweight or obesity and without type 2 diabetes, the label predicts that 25 mg a day gives blood levels comparable to 2.4 mg a week (Wegovy label, section 12.3). The spread is wider on the pill: 90% of people averaged between 27 and 186 nmol/L, against 51 and 110 nmol/L on the shot.

Type 2 diabetes is the exception. The tablets have not been studied for weight reduction in adults with type 2 diabetes, and their average levels ran lower than on the 2.4 mg injection (Wegovy label, section 8.6). The label warns that "some patients with type 2 diabetes taking WEGOVY tablets may experience subtherapeutic semaglutide blood concentrations" (Wegovy label, section 8.6).

Severe stomach and gut reactions were reported in 2% of people on the pill and none on placebo (Wegovy label, section 6.1). If the pill gives you diarrhea, the advice on eating through GLP‑1 diarrhea is the same as for the shot.

Whichever form you take, a 2025 joint advisory on GLP‑1 nutrition warns that enough protein "may be difficult to achieve due to reduced appetite" (Mozaffarian et al., 2025). It notes that 1.2 to 1.6 g per kg a day has been proposed during weight loss (Mozaffarian et al., 2025). For your own number in grams, use the GLP‑1 protein calculator.

Missed pills, travel and storage

If you miss a tablet, leave it out and take your next tablet the next day, without doubling up (Wegovy label, sections 2.1 and 2.4).

When you travel, take the tablet on waking, keep the bottle in your carry-on bag, and hold the 30-minute wait before coffee or breakfast. The label says only "in the morning", so if you work nights, ask your prescriber how that applies to your sleep pattern.

Store the tablets at room temperature, 68°F to 77°F, in their original bottle, which protects them from moisture (Wegovy label, section 16). The injection is stored in the refrigerator at 36°F to 46°F (Wegovy label, section 16). Before the cap comes off, a single-dose pen keeps at 46°F to 86°F for up to 28 days, and an opened FlexTouch pen for 56 days (Wegovy label, section 16).

Other GLP‑1 tablets

Two diabetes tablets also contain semaglutide, while Foundayo, from Lilly, is a different molecule with no fasting rule (Rybelsus and Ozempic tablets label; Foundayo label, revised July 2026).

Wegovy tablets were approved on December 22, 2025 (FDA approval letter, NDA 218316), and Foundayo followed on April 1, 2026 (FDA approval letter, NDA 220934).